TABLE OF CONTENTSÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â
1Â Â EXECUTIVE SUMMARY
2Â Â MARKET INTRODUCTION
2.1Â Â Â Â DEFINITION
2.2Â Â Â Â SCOPE OF THE STUDY
2.3Â Â Â Â RESEARCH OBJECTIVE
2.4Â Â Â Â MARKET STRUCTURE
3Â Â RESEARCH METHODOLOGY
3.1Â Â Â Â OVERVIEW
3.2Â Â Â Â DATA FLOW
3.2.1Â Â Â Â DATA MINING PROCESS
3.3Â Â Â Â PURCHASED DATABASE:
3.4Â Â Â Â SECONDARY SOURCES:
3.4.1Â Â Â Â SECONDARY RESEARCH DATA FLOW:
3.5Â Â Â Â PRIMARY RESEARCH:
3.5.1Â Â Â Â PRIMARY RESEARCH DATA FLOW:
3.6Â Â Â Â APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 Â Â REVENUE ANALYSIS APPROACH
3.7Â Â Â Â DATA FORECASTING
3.7.1Â Â Â Â DATA FORECASTING TYPE
3.8Â Â Â Â DATA MODELING
3.8.1Â Â Â Â MICROECONOMIC FACTOR ANALYSIS:
3.8.2Â Â Â Â DATA MODELING:
3.9Â Â Â Â TEAMS AND ANALYST CONTRIBUTION
4Â Â MARKET DYNAMICS
4.1Â Â Â Â INTRODUCTION
4.2Â Â Â Â DRIVERS
4.2.1Â Â Â Â INCREASING LAUNCH OF CATHETER PRODUCTS
4.2.2Â Â Â Â RISING PREVALENCE OF CHRONIC DISEASES
4.2.3Â Â Â Â FAVOURABLE REIMBURSEMENT SCENARIO
4.3Â Â Â Â RESTRAINTS
4.3.1Â Â Â Â VOLUNTARY PRODUCT RECALL BY MARKET PLAYERS
4.3.2Â Â Â Â RISK OF COMPLICATIONS AND INFECTIONS
4.4Â Â Â Â OPPORTUNITY
4.4.1Â Â Â Â GROWING GERIATRIC POPULATION ACROSS THE GLOBE
4.4.2Â Â Â Â EXPANSION AND APPROVAL OF CATHETERS
4.4.3Â Â Â Â INCREASING INVESTMENT AND ACQUISITION FOR CATHETERS
5Â Â MARKET FACTOR ANALYSIS
5.1Â Â Â Â PORTER'S FIVE FORCES MODEL
5.1.1Â Â Â Â THREAT OF NEW ENTRANTS
5.1.2Â Â Â Â BARGAINING POWER OF SUPPLIERS
5.1.3Â Â Â Â THREAT OF SUBSTITUTES
5.1.4Â Â Â Â BARGAINING POWER OF BUYERS
5.1.5Â Â Â Â INTENSITY OF RIVALRY
5.2Â Â Â Â IMPACT OF COVID-19 ON GLOBAL CATHETER MARKET
5.3Â Â Â Â MACRO INDICATORS, BY COUNTRY
5.3.1Â Â Â Â HEALTHCARE EXPENDITURE (TOTAL AND PER CAPITA)
5.3.2Â Â Â Â MORTALITY RATE
5.3.3Â Â Â Â OUT-OF-POCKET HEALTHCARE EXPENSES
5.3.4Â Â Â Â GDP
5.3.5Â Â Â Â MAJOR DISEASE
5.4Â Â Â Â PRICING ANALYSIS, 2023 (USD)
6Â Â GLOBAL CATHETERS MARKET, BY PRODUCT
6.1Â Â Â Â OVERVIEW
6.2Â Â Â Â DIALYSIS CATHETERS
6.2.1Â Â Â Â SHORT-TERM HEMODIALYSIS CATHETER
6.2.1.1 DOUBLE LUMEN CATHETERSÂ Â
6.2.1.2 TRIPLE LUMEN CATHETERSÂ Â Â Â Â
6.2.2Â Â Â Â LONG-TERM HEMODIALYSIS CATHETER
6.2.3Â Â Â Â PERITONEAL DIALYSIS CATHETER
6.2.3.1 STRAIGHT PERMANENT PERITONEAL DIALYSIS CATHETERÂ Â Â Â Â Â
6.2.3.2 CURLED PERMANENT PERITONEAL DIALYSIS CATHETERÂ Â Â Â Â Â Â Â Â
6.3Â Â Â Â UROLOGY CATHETERS
6.3.1Â Â Â Â NEPHROSTOMY SLIP-LOCK
6.3.2Â Â Â Â DOUBLE LOOP URETERAL STENT
6.3.3Â Â Â Â URETERAL STONE BASKET
6.3.4Â Â Â Â URETERIC SEQUENTIAL DILATOR
6.3.5Â Â Â Â URETHRAL BALLOON CATHETER
6.3.6Â Â Â Â URETERAL BALLOON DILATOR
6.3.7Â Â Â Â URETERAL ACCESS SHEATH
6.3.8Â Â Â Â URODYNAMIC CATHETER
6.3.9Â Â Â Â URETERIC CATHETER
6.3.10Â NELATON CATHETER
6.3.11Â NEPHROSTOMY CATHETER
6.3.12Â OTHERS
6.4Â Â Â Â INTRAVASCULAR CATHETERS
6.4.1Â Â Â Â CENTRAL VENOUS CATHETER
6.4.2Â Â Â Â ARTERIAL CATHETER
6.4.3Â Â Â Â PERIPHERAL INSERTED CENTRAL VENOUS CATHETER 'PICC'
6.4.4Â Â Â Â MIDLINE VENOUS CATHETER
6.4.5Â Â Â Â OTHERS
6.4.6Â Â Â Â ADULT
6.4.7Â Â Â Â PAEDIATRIC
7Â Â GLOBAL CATHETERS MARKET, BY END USER
7.1Â Â Â Â OVERVIEW
7.2Â Â Â Â HOSPITALS AND CLINICS
7.3Â Â Â Â AMBULATORY SURGICAL CENTERS
7.4Â Â Â Â OTHERS
8Â Â GLOBAL CATHETERS MARKET, BY REGION
8.1Â Â Â Â OVERVIEW
8.2Â Â Â Â EUROPE
8.2.1Â Â Â Â GERMANY
8.2.2Â Â Â Â FRANCE
8.2.3Â Â Â Â UK
8.2.4Â Â Â Â ITALY
8.2.5Â Â Â Â SPAIN
8.2.6Â Â Â Â NORWAY
8.2.7Â Â Â Â SWEDEN
8.2.8Â Â Â Â DENMARK
8.2.9Â Â Â Â POLAND
8.2.10Â FINLAND
8.2.11Â LITHUANIA
8.2.12Â TURKEY
8.2.13Â PORTUGAL
8.2.14Â BELGIUM
8.2.15Â NETHERLANDS
8.2.16Â RUSSIA
8.2.17Â CZECH
8.2.18Â ROMANIA
8.2.19Â REST OF EUROPE
8.3Â Â Â Â ASIA-PACIFIC
8.3.1Â Â Â Â CHINA
8.3.2Â Â Â Â INDIA
8.3.3Â Â Â Â JAPAN
8.3.4Â Â Â Â AUSTRALIA
8.3.5Â Â Â Â SOUTH KOREA
8.3.6Â Â Â Â MALAYSIA
8.3.7Â Â Â Â PHILIPPINES
8.3.8Â Â Â Â SINGAPORE
8.3.9Â Â Â Â THAILAND
8.3.10Â INDONESIA
8.3.11Â VIETNAM
8.3.12Â PAKISTAN
8.3.13Â SRI LANKA
8.3.14Â REST OF ASIA-PACIFIC
8.4Â Â Â Â LATIN AMERICA
8.4.1Â Â Â Â BRAZIL
8.4.2Â Â Â Â MEXICO
8.4.3Â Â Â Â ARGENTINA
8.4.4Â Â Â Â COLUMBIA
8.4.5Â Â Â Â DOMINICAN REPUBLIC
8.4.6Â Â Â Â CHILE
8.4.7Â Â Â Â COSTA RICA
8.4.8Â Â Â Â ECUADOR
8.4.9Â Â Â Â PERU
8.4.10Â REST OF LATIN AMERICA
8.5Â Â Â Â MIDDLE EAST
8.5.1Â Â Â Â SAUDI ARABIA
8.5.2Â Â Â Â UNITED ARAB EMIRATES (UAE)
8.5.3Â Â Â Â QATAR
8.5.4Â Â Â Â KUWAIT
8.5.5Â Â Â Â EGYPT
8.5.6Â Â Â Â JORDAN
8.5.7Â Â Â Â IRAN
8.5.8Â Â Â Â IRAQ
8.5.9Â Â Â Â OMAN
8.5.10Â YEMEN
8.5.11Â BAHRAIN
8.5.12Â REST OF MIDDLE EAST
8.6Â Â Â Â AFRICA
8.6.1Â Â Â Â SOUTH AFRICA
8.6.2Â Â Â Â NIGERIA
8.6.3Â Â Â Â MOROCCO
8.6.4Â Â Â Â KENYA
8.6.5Â Â Â Â ALGERIA
8.6.6Â Â Â Â ETHIOPIA
8.6.7Â Â Â Â REST OF AFRICA
9Â Â COMPETITIVE LANDSCAPEs
9.1Â Â Â Â INTRODUCTION
9.2Â Â Â Â MARKET SHARE ANALYSIS, 2023
9.3Â Â Â Â COMPETITOR DASHBOARD
9.4Â Â Â Â PUBLIC PLAYERS STOCK SUMMARY
9.5Â Â Â Â COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
9.6Â Â Â Â KEY DEVELOPMENTS & GROWTH STRATEGIES
9.6.1Â Â Â Â PRODUCT LAUNCH
9.6.2Â Â Â Â PRODUCT APPROVAL
9.6.3Â Â Â Â AQUISITION
9.6.4Â Â Â Â AGREEMENT
10 COMPANY PROFILES
10.1Â Â B. BRAUN SE
10.1.1Â COMPANY OVERVIEW
10.1.2Â FINANCIAL OVERVIEW
10.1.3Â PRODUCTS OFFERED
10.1.4Â KEY DEVELOPMENTS
10.1.5Â SWOT ANALYSIS
10.1.6Â KEY STRATEGIES
10.2Â Â JOHNSON & JOHNSON INC.
10.2.1Â COMPANY OVERVIEW
10.2.2Â FINANCIAL OVERVIEW
10.2.3Â PRODUCTS OFFERED
10.2.4Â KEY DEVELOPMENTS
10.2.5Â SWOT ANALYSIS
10.2.6Â KEY STRATEGIES
10.3Â Â BOSTON SCIENTIFIC CORPORATION
10.3.1Â COMPANY OVERVIEW
10.3.2Â FINANCIAL OVERVIEW
10.3.3Â PRODUCTS OFFERED
10.3.4Â KEY DEVELOPMENTS
10.3.5Â KEY STRATEGIES
10.4Â Â MEDTRONIC
10.4.1Â COMPANY OVERVIEW
10.4.2Â FINANCIAL OVERVIEW
10.4.3Â PRODUCTS OFFERED
10.4.4Â KEY DEVELOPMENTS
10.4.5Â KEY STRATEGIES
10.5Â Â ABBOTT
10.5.1Â COMPANY OVERVIEW
10.5.2Â FINANCIAL OVERVIEW
10.5.3Â PRODUCTS OFFERED
10.5.4Â KEY DEVELOPMENTS
10.5.5Â SWOT ANALYSIS
10.5.6Â KEY STRATEGIES
10.6Â Â CARDINAL HEALTH
10.6.1Â COMPANY OVERVIEW
10.6.2Â FINANCIAL OVERVIEW
10.6.3Â PRODUCTS OFFERED
10.6.4Â KEY DEVELOPMENTS
10.6.5Â SWOT ANALYSIS
10.6.6Â KEY STRATEGIES
10.7Â Â MERIT MEDICAL SYSTEMS
10.7.1Â COMPANY OVERVIEW
10.7.2Â FINANCIAL OVERVIEW
10.7.3Â PRODUCTS OFFERED
10.7.4Â SWOT ANALYSIS
10.7.5Â KEY DEVELOPMENTS
10.7.6Â KEY STRATEGIES
10.8Â Â MEDLINE INDUSTRIES, LP
10.8.1Â COMPANY OVERVIEW
10.8.2Â FINANCIAL OVERVIEW
10.8.3Â PRODUCTS OFFERED
10.8.4Â KEY DEVELOPMENTS
10.8.5Â KEY STRATEGIES
10.9Â Â COOK MEDICAL
10.9.1Â COMPANY OVERVIEW
10.9.2Â FINANCIAL OVERVIEW
10.9.3Â PRODUCTS OFFERED
10.9.4Â KEY DEVELOPMENTS
10.9.5Â KEY STRATEGIES
10.1Â Â MEDICAL COMPONENTS, INC.
10.10.1COMPANY OVERVIEW
10.10.2FINANCIAL OVERVIEW
10.10.3PRODUCTS OFFERED
10.10.4KEY DEVELOPMENTS
10.10.5KEY STRATEGIES
10.11 AMECATH
10.11.1COMPANY OVERVIEW
10.11.2FINANCIAL OVERVIEW
10.11.3PRODUCTS OFFERED
10.11.4KEY DEVELOPMENTS
10.11.5SWOT ANALYSIS
10.11.6KEY STRATEGIES
10.12 BECTON, DICKINSON AND COMPANY
10.12.1COMPANY OVERVIEW
10.12.2FINANCIAL OVERVIEW
10.12.3PRODUCTS OFFERED
10.12.4KEY DEVELOPMENTS
10.12.5SWOT ANALYSIS
10.12.6KEY STRATEGIES
10.13 TELEFLEX INCORPORATED
10.13.1COMPANY OVERVIEW
10.13.2FINANCIAL OVERVIEW
10.13.3PRODUCTS OFFERED
10.13.4KEY DEVELOPMENTS
10.13.5SWOT ANALYSIS
10.13.6KEY STRATEGIES
10.14 LEPU MEDICAL TECHNOLOGY(BEIJING)CO., LTD.
10.14.1COMPANY OVERVIEW
10.14.2FINANCIAL OVERVIEW
10.14.3PRODUCTS OFFERED
10.14.4KEY DEVELOPMENTS
10.14.5SWOT ANALYSIS
10.14.6kEY STRATEGIES
10.15 ANGIODYNAMICS
10.15.1COMPANY OVERVIEW
10.15.2FINANCIAL OVERVIEW
10.15.3PRODUCTS OFFERED
10.15.4KEY DEVELOPMENTS
10.15.5SWOT ANALYSIS
10.15.6KEY STRATEGIES
10.16 BIOTEQUE CORPORATION
10.16.1COMPANY OVERVIEW
10.16.2FINANCIAL OVERVIEW
10.16.3PRODUCTS OFFERED
10.16.4KEY DEVELOPMENTS
10.16.5SWOT ANALYSIS
10.16.6KEY STRATEGIES
10.17 COLOPLAST
10.17.1COMPANY OVERVIEW
10.17.2FINANCIAL OVERVIEW
10.17.3PRODUCTS OFFERED
10.17.4KEY DEVELOPMENTS
10.17.5KEY STRATEGIES
10.18 PRUNUS MEDICAL
10.18.1COMPANY OVERVIEW
10.18.2FINANCIAL OVERVIEW
10.18.3PRODUCTS OFFERED
10.18.4KEY DEVELOPMENTS
10.18.5KEY STRATEGIES
10.19 VYGON
10.19.1COMPANY OVERVIEW
10.19.2FINANCIAL OVERVIEW
10.19.3PRODUCTS OFFERED
10.19.4KEY DEVELOPMENTS
10.19.5KEY STRATEGIES
10.2Â Â ARGON MEDICAL DEVICE
10.20.1 COMPANY OVERVIEW
10.20.2 FINANCIAL OVERVIEW
10.20.3 PRODUCTS OFFERED
10.20.4 KEY DEVELOPMENTS
10.20.5 KEY STRATEGIES
10.21 Â Â Â Â Â GEOTEK MEDICAL
10.21.1 COMPANY OVERVIEW
10.21.2 FINANCIAL OVERVIEW
10.21.3 PRODUCTS OFFER
10.21 Â Â Â Â Â Â KEY DEVELOPMENTS
10.21.5 KEY STRATEGIES
11 DATA CITATIONS
